Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures to Operating Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 245K | 0% | $ -77.43M |
3/31/2025 | $ 314K | 0% | $ -81.23M |
12/31/2024 | $ 310K | 0% | $ -86.23M |
9/30/2024 | $ 496K | 0% | $ -88.29M |
6/30/2024 | $ 486K | 0% | $ -85.8M |
3/31/2024 | $ 907K | 0% | $ -91.43M |
12/31/2023 | $ 840K | 0% | $ -56.03M |
9/30/2023 | $ 756K | 0% | $ -35.47M |
6/30/2023 | $ 1.16M | 0% | $ -51.07M |
3/31/2023 | $ 1.05M | 0% | $ -60.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for CYTOMX THERAPEUTICS INC is calculated as follows: CapEx [ $ 2.57M ] / CF - Operations [ $ -6.79M ]
(=) CapEx/OCF [ 0% ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.35K |
---|---|
min | 0.01% |
max | 128% |
average | 31.8% |
median | 22.41% |
std | 29.52% |